9 resultater
FIELD OF THE INVENTION
The present invention pertains to a pharmaceutical composition comprising .DELTA.9 Tetrahydrocannabinol (THC), Cannabidiol (CBD), at least one small molecule selected from Citric Acid, Ascorbic Acid, Citrus Essential Oil(s), Lecithin, one or more sugar(s), Resveratrol, and
RELATED PATENT APPLICATIONS
There are no related patent applications.
FIELD OF THE INVENTION
The present invention generally relates to a composition that combines creamer and a cannabinoid and further a kit for making a creamer and cannabinoid composition for human consumption. More particularly
FIELD OF THE INVENTION
The present invention pertains to a pharmaceutical composition comprising .DELTA.9 Tetrahydrocannabinol (THC), Cannabidiol (CBD), and at least one small molecule selected from Citric Acid, Ascorbic Acid, Citrus Essential Oil(s), Lecithin, one or more sugar(s), Resvertrol, and
FIELD OF THE INVENTION
The present invention pertains to a pharmaceutical composition comprising .DELTA.9 Tetrahydrocannabinol-(THC), Cannabidiol (CBD), and a cytochrome p450 enzyme inhibitor.
BACKGROUND OF THE INVENTION
Cannabinoids are a group of chemicals from Cannabis Sativa or Cannabis indica
FIELD OF THE INVENTION
The invention relates to a composition with a pharmacological effect. More specifically, the invention relates to a composition with a pharmacological effect that can be administered via vaporization.
BACKGROUND
Combusting and inhaling an organic compound can cause a user to
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims priority to pending U.S. application Ser. No. 14/561,091 entitled "Transdermal Cannabinoid Formulations", filed Dec. 4, 2014, now U.S. Pat. No. 9,375,417, issued Jun. 28, 2016, the disclosure of which is hereby incorporated by reference
BACKGROUND
The clinical usefulness of the cannabinoids, including 11.sup.9-tetrahydrocannabinol (/1.sup.9-THC), to provide analgesia, help alleviate nausea and emesis, as well as stimulate appetite has been well-recognized. Cannabinoids offer a variety of pharmacological benefits, including, but not
BACKGROUND
The clinical usefulness of the cannabinoids, including .DELTA..sup.9-tetrahydrocannabinol (.DELTA..sup.9-THC), to provide analgesia, help alleviate nausea and emesis, as well as stimulate appetite has been well-recognized. Cannabinoids offer a variety of pharmacological benefits,
FIELD OF THE INVENTION
The present invention relates to cannabis infused sweeteners and elixirs that are bio-available, fast acting and highly metabolizable.
BACKGROUND OF THE INVENTION
Cannabinoids are chemical compounds found in the cannabis plant that interact with receptors in the brain and body